Opinions in Healthcare

Bioidentical hormones are structures that mimic those of human steroid hormones. These substances are derived from plant oils through a chemical conversion process to the plant. The products are a match in structure

Kisunla: A New Breakthrough for Alzheimer’s Disease The FDA’s approval of Kisunla (donanemab-azbt) marks a significant advancement in the treatment of early-stage Alzheimer’s disease. Kisunla was developed by Eli Lilly, and this new

What is Compounding? Today, compounding is a practice generally conducted by a licensed pharmacist or outsourcing facility requiring discipline and precision. The core demand for compounding pharmacies is the necessity of a formulation

On May 24, 2024, the FDA approved Onyda XR (clonidine hydrochloride), a liquid non-stimulant medication for attention deficit hyperactivity disorder (ADHD). Developed by Tris Pharma, Onyda XR is a centrally acting alpha 2

On July 13, 2023, the FDA approved the first over-the-counter birth control called ‘Opill’. An increased availability of hormonal birth control without a prescription may increase access and remove the barriers that individuals

On July 18th, 2023, the FDA approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) in neonates and infants born during or entering their first RSV season, and in children up

Telehealth’s Sudden Rise The Impact of Telehealth Post-COVID Telehealth Expansion Act Resources https://bipartisanpolicy.org/report/future-of-telehealth/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013549/ https://www.healthcareitnews.com/news/what-telehealth-expansion-act-means-tackling-social-determinants-and-boosting-health-equity#:~:text=The%20passing%20of%20the%20Telehealth,of%20location%20or%20socioeconomic%20status. Melissa Alex, PharmD Candidate 2024

Insomnia, a common sleep disorder, has various causes, including stress, poor sleep habits, medical conditions, medications, and age-related changes in sleep patterns. Understanding these causes is crucial for tailoring effective treatments and improving

Symbicort is a pressurized metered dose inhaler used in patients with moderate to severe asthma who are at least 6 years old, and for chronic obstructive pulmonary disorder (COPD) who are at least